NCT05364060

Brief Summary

Research Hypothesis: Living conditions during COVID-19, and lockdowns and curfews impact the psychological state of patients (assessed by the degree of depression, positive and negative thoughts, insomnia, state of post-traumatic stress).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
585

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 6, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 13, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2023

Completed
Last Updated

November 10, 2022

Status Verified

November 1, 2022

Enrollment Period

1 year

First QC Date

May 5, 2022

Last Update Submit

November 7, 2022

Conditions

Keywords

covid-19psychiatry

Outcome Measures

Primary Outcomes (1)

  • Evaluation of prevalence of severe depression in patients followed in psychiatry in the department of Eure

    The scale used is BDI-FS-Fr (Beck Depression Inventory-Fast Screen-French) scale, composed of seven self-assessment items taken from the 21 items of the BDI-II. The BDI-FS-Fr has been validated in France.

    Baseline

Secondary Outcomes (4)

  • Describe population characteristics

    Baseline

  • Evaluation of sleep disorder

    Baseline

  • Evaluation of post-traumatic stress disorder

    Baseline

  • Evaluation of positive and negative thoughts

    Baseline

Study Arms (1)

patients followed in psychiatry

Quantitative questionnaires

Other: Questionnaires

Interventions

Different questionnaires detailed in the objectives part

patients followed in psychiatry

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients coming for a psychiatric consultation or hospitalization at the New Hospital of Navarre or in the extra-hospital centers of the department of Eure

You may qualify if:

  • At least 18 years old
  • Coming for a psychiatric consultation or hospitalization at the New Hospital of Navarre or in the extra-hospital centers of the department of Eure
  • Patient who has received the information note and who does not refuse to participate in the study

You may not qualify if:

  • Patient not understanding French
  • Patient followed in psychiatry for a major cognitive disorder
  • Patient under legal protection measure (guardianship, curatorship, safeguard of justice, future protection mandate or family authorization)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CH Eure-Seine

Évreux, 27015, France

RECRUITING

MeSH Terms

Conditions

COVID-19Mental Disorders

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Tarik Mazouzi, MD

    New Hospital of Navarre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2022

First Posted

May 6, 2022

Study Start

June 13, 2022

Primary Completion

June 13, 2023

Study Completion

June 13, 2023

Last Updated

November 10, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations